Agenus (AGEN) Director Susan Hirsch Receives 50,000-Share Option Award

What Happened Susan B. Hirsch, a director of Agenus Inc. (AGEN), received a derivative award on 2026-08-05 for 50,000 shares (reported as $0.00 acquired). The filing indicates these are option awards under Agenus’ equity incentive plan — no cash changed hands at grant. This is an award (A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-05; Form 4 filed: 2026-08-07 (timely, within the usual two-business-day reporting window).
• Price shown: $0.00 (award/grant); reported as a derivative instrument (option award).
• Shares granted: 50,000 (underlying shares of the option award).
• Shares owned after transaction: Not specified in the Form 4 provided.
• Footnote: Awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan; vests over three years — 1/3 on the first anniversary, then the remaining 2/3 in two equal annual installments.
• No 10b5-1 plan, tax-withholding, or sale reported in this filing.

Context This filing documents a standard director equity grant (option award) used for compensation and retention. It is a derivative grant — Hirsch does not receive tradable shares immediately; she will only acquire shares if and when the options vest and are exercised (exercise price not specified in this Form 4). Such grants are routine and do not by themselves indicate immediate buying or selling of company stock.